Meeting
2016 ASCO Annual Meeting
Doxorubicin plus dacarbazine (DTIC) in advanced solitary fibrous tumor (SFT): An Italian retrospective case series analysis.
Authors
Maristella Saponara
Department of specialized, experimental, and diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Maristella Saponara , Bruno Vincenzi , Giuseppe Badalamenti , Carlo Morosi , Silvana Pilotti , Gianpaolo Dagrada , Salvatore Provenzano , Michela Libertini , Rossella Bertulli , Vittoria Colia , Angelo Paolo Dei Tos , Paolo Giovanni Casali , Silvia Stacchiotti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Sarcoma
Track
Sarcoma
Sub Track
Soft Tissue Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11042)
DOI
10.1200/JCO.2016.34.15_suppl.11042
Abstract #
11042
Poster Bd #
168
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Trabectedin (T) versus adriamycin plus dacarbazine (A-DA) in advanced solitary fibrous tumor (SFT): Results from a phase II randomised clinical study (STRADA).
First Author: Silvia Stacchiotti
Poster
2020 ASCO Virtual Scientific Program
A Big Ten Cancer Research Consortium phase II trial of pembrolizumab with carboplatin and paclitaxel for advanced or recurrent endometrial cancer.
First Author: Mario Javier Pineda
Poster
2014 ASCO Annual Meeting
Defining the chemotherapy (CT) response in well-differentiated (WD) and dedifferentiated (DD) liposarcomas (LPS) of the retroperitoneum (RP): A tertiary referral cancer center experience.
First Author: Neeta Somaiah
Poster
2021 ASCO Annual Meeting
Regorafenib (R) in advanced solitary fibrous tumor (SFT): Results from an exploratory phase II clinical study.
First Author: Silvia Stacchiotti